日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial

Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌:一项II期试验

Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume

A prospective trial for breast cancer diagnosis by canine odorology

一项利用犬类气味诊断乳腺癌的前瞻性试验

Tardivon, Anne; Mesurolle, Benoit; Dureau, Sylvain; Poncelet, Edouard; Dravet, François; Langer, Adriana; El Bejjani, Marie-Rose; Alran, Séverine; Deluche, Elise; Savignoni, Alexia; Kadi, Amir; Bauër, Pierre; Gilbert, Caroline; Leemans, Michelle; Fromantin, Isabelle

PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network

PARP抑制剂作为铂敏感复发后卵巢癌的维持治疗:来自Unicancer网络的真实世界经验

Rippstein, Nicolas; Zemmour, Christophe; Rodrigues, Manuel; Ray-Coquard, Isabelle; Gladieff, Laurence; Pautier, Patricia; Frénel, Jean-Sébastien; Costaz, Hélène; Lebreton, Coriolan; Pomel, Christophe; Colombo, Pierre-Emmanuel; Marchal, Frédéric; Guillemet, Cécile; de la Motte Rouge, Thibault; Eberst, Lauriane; Bosquet, Lise; Deluche, Elise; Sabatier, Renaud

Evaluation of end-of-Life chemotherapy: a medical and economic challenge revealed by a retrospective observational study

生命末期化疗的评估:一项回顾性观察研究揭示的医学和经济挑战

Agius, Paul; Léobon, Sophie; Maillan, Gaëlle; Deluche, Élise

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

给药顺序的疗效:Sacituzumab Govitecan 和 Trastuzumab Deruxtecan 治疗 HER2 低表达转移性乳腺癌

Poumeaud, F; Morisseau, M; Cabel, L; Gonçalves, A; Rivier, C; Trédan, O; Volant, E; Frenel, J-S; Ladoire, S; Jacot, W; Jamelot, M; Foka Tichoue, H; Patsouris, A; Teixeira, L; Bidard, F-C; Loirat, D; Brunet, M; Levy, C; Bailleux, C; Cabarrou, B; Deleuze, A; Uwer, L; Deluche, E; Grellety, T; Franchet, C; Fiteni, F; Bischoff, H; Vion, R; Pagliuca, M; Verret, B; Bécourt, S; Reverdy, T; de Nonneville, A; Dalenc, F

Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial

曲妥珠单抗德鲁替康治疗 HER2 表达可变的转移性乳腺癌:第 2 期 DAISY 试验

Fernanda Mosele, Elise Deluche #, Amelie Lusque #, Loïc Le Bescond #, Thomas Filleron, Yoann Pradat, Agnes Ducoulombier, Barbara Pistilli, Thomas Bachelot, Frederic Viret, Christelle Levy, Nicolas Signolle, Alexia Alfaro, Diep T N Tran, Ingrid Judith Garberis, Hugues Talbot, Stergios Christodoulidis

Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia

腰大肌指数不能代表骨骼肌指数,因此不适用于评估癌症引起的肌肉减少症。

Pigneur, Frédéric; Di Palma, Mario; Raynard, Bruno; Guibal, Aymeric; Cohen, Frédéric; Daidj, Nassima; Aziza, Richard; El Hajjam, Mostafa; Louis, Guillaume; Goldwasser, François; Deluche, Elise

Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

晚期实体瘤治疗失败患者高通量测序鉴定的分子改变的临床管理:来自法国一家医院的真实世界数据

Pinet, Sandra; Durand, Stéphanie; Perani, Alexandre; Darnaud, Léa; Amadjikpe, Fifame; Yon, Mathieu; Darbas, Tiffany; Vergnenegre, Alain; Egenod, Thomas; Simonneau, Yannick; Le Brun-Ly, Valérie; Pestre, Julia; Venat, Laurence; Thuillier, Frédéric; Chaunavel, Alain; Duchesne, Mathilde; Fermeaux, Véronique; Guyot, Anne; Lacorre, Sylvain; Bessette, Barbara; Lalloué, Fabrice; Durand, Karine; Deluche, Elise

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings

在真实世界环境中,对于激素受体阳性、人表皮生长因子受体2阴性的乳腺癌,基因组检测建议在指导辅助化疗决策中的应用情况

Hequet, D; Hajjaji, N; Charafe-Jauffret, E; Boucrauta, A; Dalenc, F; Nicolai, V; Lopez, J; Tredan, O; Deluche, E; Fermeaux, V; Tixier, L; Cayre, A; Menet, E; Lerebours, F; Rouzier, R

Patient Identification and Tumor Identification Management: Quality Program in a Cancer Multicentric Clinical Data Warehouse

患者识别和肿瘤识别管理:癌症多中心临床数据仓库中的质量计划

Pallier, Karine; Prot, Olivier; Naldi, Simone; Silva, Francisco; Denis, Thierry; Giry, Olivier; Leobon, Sophie; Deluche, Elise; Tubiana-Mathieu, Nicole